Closed

Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors

Description: This competitive combined synopsis/solicitation seeks medicinal chemistry support for therapeutic development involving the synthesis of HERV-K protease inhibitors. The National Institutes of Health Office of Logistics and Acquisition Operations issued solicitation 75N98026Q00906 for commercial products or commercial services, so it is a procurement solicitation rather than a grant program. Responses are due August 10, 2026, at 9:00 AM, and the notice was issued July 31, 2026.

Buyer: National Institutes of Health OLAO
Federal · MD, US
Released: Jul 31, 2026
Closes: Aug 10, 2026(Closed)

Files

Original attachments and procurement documents tied to this bid.

Federal RFP files are for Starbridge customers only.

You can request RFP files from all other buyer types for free on this site.

Active alternatives to this closed RFP

These related opportunities are still open for bidding.

National Institutes of Health OLAO
FederalMD
Open
Jul 31, 2026
Closes
Aug 10, 2026
Medicinal Chemistry Support for Therapeutic Development: Synthesis of HERV-K Protease Inhibitors RFP
This competitive combined synopsis/solicitation seeks medicinal chemistry support for therapeutic development involving the synthesis of HERV-K protease inhibitors. The National Institutes of Health Office of Logistics and Acquisition Operations issued solicitation 75N98026Q00906 for commercial products or commercial services, so it is a procurement solicitation rather than a grant program. Responses are due August 10, 2026, at 9:00 AM, and the notice was issued July 31, 2026.
National Institutes of Health
FederalMD
Open
Aug 7, 2026
Closes
Aug 24, 2026
Developing selective small-molecule inhibitors of
The National Institutes of Health, Office of the Director, Office of Acquisitions is soliciting proposals under Solicitation 75N98026Q00986, Developing selective small-molecule inhibitors of. This is a competitive, full-and-open, firm-fixed-price commercial contract solicitation for research and development related to selective small-molecule inhibitors. Offers are due August 24, 2026, at 8:00 AM EDT, and the official posting includes a publicly available PDF solicitation attachment.
National Institutes of Health
FederalMD
Open
Aug 7, 2026
Closes
Aug 24, 2026
Developing selective small-molecule inhibitors of RFP
The National Institutes of Health, Office of the Director, Office of Acquisitions is soliciting proposals under Solicitation 75N98026Q00986, Developing selective small-molecule inhibitors of. This is a competitive, full-and-open, firm-fixed-price commercial contract solicitation for research and development related to selective small-molecule inhibitors. Offers are due August 24, 2026, at 8:00 AM EDT, and the official posting includes a publicly available PDF solicitation attachment.
National Institutes of Health OLAO
FederalMD
Open
Aug 7, 2026
Closes
Aug 24, 2026
Synthesis of compounds and intermediates
This is a competitive combined synopsis/solicitation for commercial products or commercial services prepared under FAR Subpart 12.6, and no separate written solicitation will be issued. The National Institutes of Health Office of the Director, Office of Acquisitions seeks a firm-fixed-price award for the synthesis of compounds and intermediates through full and open competition. The solicitation was published on August 7, 2026, and offers are due August 24, 2026 at 8:00 a.m. EDT while the opportunity remains active as of August 8, 2026.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.

See your top 10 accounts